000			02022 a2200577 4500
005			20250514225751.0
264		0	_c20050802
008			200508s 0 0 eng d
022			_a1097-6256
024	7		_a10.1038/nn1467 _2doi
040			_aNLM _beng _cNLM
100	1		_aMeier, Jochen C
245	0	0	_aRNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency. _h[electronic resource]
260			_bNature neuroscience _cJun 2005
300			_a736-44 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAction Potentials _xdrug effects
650	0	4	_aAmino Acid Sequence
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aChloride Channel Agonists
650	0	4	_aChloride Channels _xdrug effects
650	0	4	_aCytidine _xmetabolism
650	0	4	_aDeamination
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aGlycine _xmetabolism
650	0	4	_aMolecular Sequence Data
650	0	4	_aNeural Inhibition _xdrug effects
650	0	4	_aNeurons _xdrug effects
650	0	4	_aOrgan Culture Techniques
650	0	4	_aPatch-Clamp Techniques
650	0	4	_aProtein Isoforms _xagonists
650	0	4	_aProtein Processing, Post-Translational _xdrug effects
650	0	4	_aProtein Synthesis Inhibitors _xpharmacology
650	0	4	_aRNA Editing _xgenetics
650	0	4	_aRNA, Messenger _xantagonists & inhibitors
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Glycine _xagonists
650	0	4	_aSuperior Colliculi _xanatomy & histology
700	1		_aHenneberger, Christian
700	1		_aMelnick, Igor
700	1		_aRacca, Claudia
700	1		_aHarvey, Robert J
700	1		_aHeinemann, Uwe
700	1		_aSchmieden, Volker
700	1		_aGrantyn, Rosemarie
773	0		_tNature neuroscience _gvol. 8 _gno. 6 _gp. 736-44
856	4	0	_uhttps://doi.org/10.1038/nn1467 _zAvailable from publisher's website
999			_c15557555 _d15557555